Nonclinical service CRO Envigo is merging with publicly traded Avista Healthcare Public Acquisition Corporation.

Charles River Laboratories is buying CRO Brains On-Line for €18 million as it further strengthens its offers in CNS early-stage drug research.

Icon strengthens real-world evidence offerings by acquiring health research and commercialization company Mapi.

German CRO Evotec is acquiring U.S. counterpart Aptuit in a $300 million deal.

WuXi Biologics is pricing its shares at HK$20.60, the top end of its marketing range, valuing the IPO at $510 million, Bloomberg reports.

Outcome Health, a healthcare intelligence tech firm, has raised an outsize $500 million first round of funding, valuing it at $5.5 billion.

Medical device-focused CRO Genae has invested an undisclosed amount in Meditrix, a Japanese CRO in that same field, and obtained a call option to acquire the…

Chiltern has acquired Japanese CRO Integrated Development Associates (IDA), strengthening its presence in Asia.